An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer - Concepedia

Concepedia

Publication | Open Access

An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer

DOI Full Paper Access

93

Citations

15

References

2003

Year

Marcus J. Drake, Wendy Robson, P. Mehta, Ian Schofield, David E. Neal, Hing Y. Leung

British Journal of Cancer

References

	Year	Citations

Page 1